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Purpose: Keratoconus (KTCN) is a non-inflammatory, usually bilateral disorder of the eye which results in the conical
shape and the progressive thinning of the cornea. Several studies have suggested that genetic factors play a role in the
etiology of the disease. Several loci were previously described as possible candidate regions for familial KTCN; however,
no causative mutations in any genes have been identified for any of these loci. The purpose of this study was to evaluate
role of the collagen genes collagen type IV, alpha-1 (COL4A1) and collagen type IV, alpha-2 (COL4A2) in KTCN in
Ecuadorian families.
Methods: COL4A1 and COL4A2 in 15 Ecuadorian KTCN families were examined with polymerase chain reaction
amplification, and direct sequencing of all exons, promoter and intron-exon junctions was performed.
Results: Screening of COL4A1 and COL4A2 revealed numerous alterations in coding and non-coding regions of both
genes. We detected three missense substitutions in COL4A1: c.19G>C (Val7Leu), c.1663A>C (Thr555Pro), and c.
4002A>C (Gln1334His). Five non-synonymous variants were identified in COL4A2: c.574G>T (Val192Phe), c.1550G>A
(Arg517Lys), c.2048G>C (Gly683Ala), c.2102A>G (Lys701Arg), and c.2152C>T (Pro718Ser). None of the identified
sequence variants completely segregated with the affected phenotype. The Gln1334His variant was possibly damaging to
protein function and structure.
Conclusions: This is the first mutation screening of COL4A1 and COL4A2 genes in families with KTCN and linkage to
a locus close to these genes. Analysis of COL4A1 and COL4A2 revealed no mutations indicating that other genes are
involved in KTCN causation in Ecuadorian families.
Keratoconus  (KTCN,  OMIM  148300)  is  a  non-
inflammatory,  usually  bilateral  disorder  of  the  eye,
characterized by progressive thinning and protrusion of the
central cornea which results in altered refractive powers and
loss of visual acuity [1]. The prevalence of the disease is
estimated to be 1 in 2,000 individuals, and is the most common
ectatic disorder of the cornea [1]. KTCN afflicts males and
females in all ethnic groups [1]. Signs and symptoms depend
on the stage of disease, with the first signs usually appearing
in the third decade of life [1,2]. The cause of KTCN is still
unknown; both genetic and environmental factors seem to
play a role in its etiology. Although most cases of KTCN are
isolated, an association with many syndromes, such as Down
syndrome  [3],  Ehlers-Danlos  syndrome  [4],  and  Leber
congenital amaurosis [5] has been described. Furthermore,
extensive studies have shown an association between KTCN
and constant eye rubbing [6], contact lens wear [7], or atopy
[8]. Usually, KTCN is a sporadic disorder, but positive family
history  has  been  observed  in  6%–8%  of  cases  [1].  An
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autosomal  dominant  inheritance  pattern  with  reduced
penetrance has been suggested in 90% of patients with familial
KTCN [9,10].
Genomewide linkage analyses have indicated several loci
involved in the etiology of familial KTCN at 16q22.3-q23.1
(KTCN2;  OMIM  608932),  3p14-q13  (KTCN3;  OMIM
608586), 2p24 (KTCN4; OMIM 609271), 1p36.23–36.21,
5q14.3-q21.1,  5q21.2,  5q32-q33,  8q13.1-q21.11,  9q34,
14q11.2,  14q24.3,  15q2.32,  15q22.33-q24.2,  17p13,  and
20q12 [10-20]. However, no mutations in any genes at any of
these loci have been associated with KTCN.
We have demonstrated an evidence of linkage to a novel
locus at 13q32 [21]. Collagen type IV, alpha-1 (COL4A1;
OMIM 120130) and collagen type IV, alpha-2 (COL4A2;
OMIM 120090) are mapped in close proximity to that locus.
The COL4A1 and COL4A2 genes are organized in a head-to-
head conformation [22]. These gene pairs share a common
promoter, and each gene is transcribed in opposite directions
[23]. The COL4A1 gene is placed on the minus strand and
consists  of  52  exons,  while  the  COL4A2  gene  is  on  the
opposite strand and consists of 48 exons. They encode two of
six collagen type IV chains – α1 and α2 (1,669 and 1,712
amino acids, respectively) – forming a heterotrimeric protein
molecule of collagen type IV (α1α1α2), which is found in the
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827structure  of  the  basement  membrane  (BM)  [22,23].  Each
chain contains three domains: an NH2-terminal 7S domain, a
major  collagenous  domain  with  Gly-X-Y  repeats  (the  X
position is frequently occupied by proline, whereas the Y
position is often occupied by 4-hydroxyproline) and a non-
collagenous  domain  (NC1)  at  the  COOH-terminus.
Repetitions of the Gly-X-Y motif determine the formation of
the triple-helical structure of collagen [22].
Collagens are the major protein components of the human
cornea, and several types of collagen, including collagen type
IV,  have  been  identified  [24].  Biochemical  studies  have
revealed thinning of corneas from patients with KTCN, which
may occur as a result of a reduced amount of total collagen
proteins [25] and changes in collagen fibers orientation [26].
Moreover, a cornea affected by KTCN contains defects in BM
and alterations in the BM composition [27]. The presence of
collagen  type  IV  in  normal  human  cornea  has  remained
unclear [28]. Results from expression arrays have shown an
expression  of  COL4A1  in  transplant-quality  human  donor
corneas [29] and a downregulation of COL4A1 in keratoconus
corneas  [30].  Immunohistochemical  studies  have  found
collagen type IV α1/α2 chains in keratoconus corneas in large
defect  sites  [28].  In  light  of  these  results,  we  recognize
COL4A1 and COL4A2 as candidate genes for KTCN.
The purpose of this study was to screen COL4A1 and
COL4A2 genes and determine whether sequence variants in
these  genes  are  involved  in  the  causation  of  KTCN
in Ecuadorian families.
METHODS
Subjects: Twenty-three individuals from family KTCN-014,
25 affected individuals from other Ecuadorian families with
KTCN, and 64 Ecuadorian control subjects were included in
the study. The pedigrees of these families have been described
elsewhere [21]. All individuals were examined in the Hospital
Metropolitano  in  Quito,  Ecuador,  undergoing  a  complete
ophthalmic  evaluation  as  previously  described  [21].  The
possible  consequences  of  the  study  were  explained  and
informed consent was obtained from all family members,
according to the Declaration of Helsinki. Study protocol was
approved  by  both  the  Institutional  Review  Board  at
Washington  State  University  Spokane,  Spokane,  WA  and
Poznan University of Medical Sciences (Poland).
Sequencing analyses: Oligonucleotide primers were designed
to amplify all coding sequences and intron-exon junctions,
promoter, and UTRs of both COL4A1 and COL4A2 (Table 1).
PCR  amplifications  were  performed  using  Taq  DNA
Polymerase  (Fermentas  Inc.,  Glen  Burnie,  MD).  PCR
products were purified with ExoSAP-IT® (USB Corporation,
Cleveland, OH) or Montage® PCR Filter Units (Millipore,
Jaffrey, NH) and sequenced using the BigDye® Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems, Inc. [ABI],
Foster  City,  CA).  Sequencing  was  visualized  on  an  ABI
PRISM® 3100 Genetic Analyzer (ABI) and a 3730xl DNA
Analyzer (ABI). The DNA sequences of study subjects were
compared  with  the  reference  sequences  of  COL4A1  and
COL4A2 (GRCh37/hg19, GenBank accession numbers for
the mRNA NM_001845.4 and NM_001846.2, respectively)
using  Sequencher®  4.1.4.  Software  (Gene  Codes
Corporation, Ann Arbor, MI).
Haplotype analysis: PEDSTATS [31] was used to verify the
structure  of  KTCN-014  family  and  identify  potential
Mendelian  inconsistencies  in  the  inheritance  of  single
nucleotide polymorphisms (SNPs) in COL4A1 and COL4A2.
For that region, to determine the full haplotypes inherited
along with the substitutions occurring in affected individuals,
a reconstruction of observed sequence variants was prepared
using SimWalk2 [32,33]. Allele frequencies were set as equal.
The location of genetic markers was determined on the basis
of the Rutgers combined linkage-physical map of the human
genome [34], either directly or by interpolation. Haplotype
was generated with HaploPainter [35].
Statistical  analysis  for  Gln1334His  substitution:  The
difference in distribution of Gln1334His substitution between
affected and unaffected individuals in family KTCN-014 was
analyzed by Fisher's Exact Test for Count Data. Similarly, 25
affected  individuals  from  the  remaining  KTCN  families
versus  64  Ecuadorian  control  individuals  were  compared
using  Fisher's  Exact  Test.  The  difference  between  the
examined groups was considered significant if the value of
probability (p) did not exceed 0.05.
Prediction of effect of amino acid substitutions on protein
function: The potential impact of amino acid substitutions on
the  COL4A1  and  COL4A2  proteins  was  examined  using
PolyPhen, SIFT, PMUT, PANTHER, and SNAP tools.
The PolyPhen tool predicts which missense substitution
affects the structure and function of protein, and uses Position-
Specific Independent Counts software to assign profile scores.
These scores are the likelihood of the occurrence of a given
amino acid at a specific position, compared to the likelihood
of this amino acid occurring at any position (background
frequency) [36].
The SIFT analytic tool, on the basis of gene sequences
homology, evaluates conserved positions, and calculates a
score for the amino acid change at a particular position. A
score  of  <0.05  is  considered  as  pathogenic  and  has  a
phenotypic effect on protein structure [37].
The PMUT calculates the pathological significance of
non-synonymous  amino  acid  substitution  using  neural
networks (NN). NN output >0.5 is considered to be deleterious
[38].  PANTHER  estimates  the  likelihood  of  a  particular
amino acid’s change affecting protein function. On the basis
of an alignment of evolutionarily related proteins, it generates
the substitution Position-Specific Evolutionary Conservation
(subPSEC).  The  subPSEC  could  achieve  values  from  0
(neutral) to about −10 (most likely to be deleterious). The
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831value −3 is the cutoff point for functional significance, and
corresponds to a Pdeleterious of 0.5. If the substitution occurs at
a position not appearing in the multiple sequence alignment,
a subPSEC score cannot be calculated and change is not likely
to be pathogenic [39,40].
The SNAP tool predicts the functional consequences of
exchanging amino acids using evolutionary conservation and
structure/function  relationships.  The  SNAP  output  shows
prediction neutral or non-neutral, and the expected accuracy
[41].
RESULTS
Forty  eight  members  of  15  Ecuadorian  families  and  64
Ecuadorian  control  subjects  were  included  in  the  study.
Twenty-three  individuals  from  family  KTCN-014,  two
affected individuals from each of the families KTCN-011,
015, 019, 020, 021, 024, 025, 030, 031, 034, and 035, and one
patient from each of KTCN-05, 013, and 017 were examined.
COL4A1 and COL4A2 sequence analyses: Screening of
COL4A1  (NM_001845.4)  coding  regions  revealed  12
sequence  variants,  three  of  which  were  amino  acid
substitutions: c.19G>C (Val7Leu), c.1663A>C (Thr555Pro),
and  c.4002A>C  (Gln1334His).  We  identified  one  novel
synonymous change, c.3693G>A (Thr1231Thr), and eight
previously  reported  sequence  variants:  c.432T>A
(Ala144Ala),  c.1257T>C  (Pro419Pro),  c.1815T>C
(Pro605Pro),  c.2130G>A  (Pro710Pro),  c.3183G>A
(Gly1061Gly),  c.3189A>T  (Arg1063Arg),  c.4470C>T
(Ala1490Ala),  and  c.4800C>T  (Ser1600Ser).  In  the  5′
untranslated region (5′ UTR), one novel sequence variant, c.
84+124T>A, was identified. In the 3′ untranslated region (3′
UTR),  two  previously  reported  variants,  c.*587C>A  and
c.*975A>C, were detected.
Sequencing analyses of COL4A2 (NM_001846.2) coding
regions revealed 13 previously reported sequence variants,
including  five  non-synonymous  substitutions:  c.574G>T
(Val192Phe),  c.1550G>A  (Arg517Lys),  c.2048G>C
(Gly683Ala),  c.2102A>G  (Lys701Arg),  and  c.2152C>T
(Pro718Ser), and eight synonymous substitutions: c.297G>A
(Thr99Thr),  c.1008C>T  (Pro336Pro),  c.1095G>A
(Pro365Pro),  c.1179C>T  (Ile393Ile),  c.1488G>A
(Pro496Pro),  c.4089G>A  (Ala1363Ala),  c.4290T>C
(Phe1430Phe), c.4515A>G (Pro1505Pro). In the 5′ UTR, five
known  nucleotide  changes,  c.-277A>C,  c.-232C>G,
c.-215C>T, c.-203T>C, and c.-133A>G, were identified. In
the  3′  UTR,  eight  previously  reported  sequence  variants,
c.*76T>C,  c.*101_*102del2,  c.*417C>G,  c.*541C>T,
c.*557A>G, c.*650T>C, c.*663T>C, and c.*727G>C were
detected.
Screening  of  exon/intron  junctions  in  COL4A1  and
COL4A2  revealed  numerous  sequence  variants  in  the
surrounding non-coding sequences, 71 and 86, respectively,
including single nucleotide changes, insertions, and deletions.
All screening results are summarized in Table 2.
The sequencing of the genomic region containing the
common  promoter  of  COL4A1  and  COL4A2  revealed  no
sequence changes.
Statistical analysis and in silico predictions: PolyPhen
analyses  of  non-synonymous  changes  in  COL4A1  and
COL4A2  predicted  that  only  the  Gln1334His  variant  in
COL4A1 was possibly damaging for protein function and
structure  (Table  3).  The  multiple  sequence  alignment  of
COL4A1 orthologs shows that the amino acid glutamine at
position 1,334 is conserved throughout the analyzed species
(Figure  1).  Gln1334His  substitution  was  observed  more
frequently in patients than in healthy individuals in family
KTCN-014  (p=0.056).  There  was  no  difference  in  the  c.
4002A>C allele distribution between the analyzed affected
individuals  from  the  remaining  KTCN  families  and  the
Ecuadorian control subjects (p=0.17).
The  SIFT,  PMUT,  PANTHER,  and  SNAP  analyses
defined all missense amino acid substitutions in COL4A1 and
COL4A2 as neutral/tolerated and lacking any effect on protein
function. All prediction results are summarized in Table 3.
Haplotype  reconstruction:  Haplotypes  of  sequence
variants observed in family KTCN-014 are shown in Figure
2. The coding sequence variants in COL4A1 are surrounded
by markers rs13260 and col4a1_snp2. Exons of COL4A2 are
localized between rs35466678 and rs422733.
KTCN-014  consists  of  two  family  branches.  Distinct
haplotypes in the branches were identified (Figure 2). In the
first one, initiated by parents KTCN-93 and KTCN-01, six
subjects with KTCN had the same haplotype in the COL4A1
region,  extending  from  rs13260  to  col4a1_snp1.  Three
unaffected individuals, KTCN-13, KTCN-14, and KTCN-22,
share that part of the haplotype with their affected relatives.
One of four variants in this region, rs3742207, causes a change
in the protein sequence, replacing Gln in position 1334 with
His (Gln1334His). That haplotype region, from rs13260 to
col4a1_snp1, represents a short fragment of the haplotype
which covers the whole COL4A1 and COL4A2 sequence in
KTCN-03, KTCN-05, KTCN-06, and KTCN-14. In addition,
individuals KTCN-07, KTCN-09, KTCN-13, KTCN-22, and
KTCN-23 share the rs874203-rs422733 region (Figure 2 –
pink  bars).  For  markers  rs13260-col4a1_snp1,  a  different
haplotype was observed in the second family branch, initiated
by parents KTCN-92 and KTCN-16. This haplotype covered
the entire length of the analyzed region, and was identified in
all affected individuals and KTCN-21, whose phenotype was
unknown. Subject KTCN-17 had the same allele pattern for
markers s13260-col4a1_snp1, as individuals from the first
branch of the family. However, in this case, analysis indicated
that  these  markers  are  inherited  from  KTCN-92,  who  is
unrelated to KTCN-93 and KTCN-01.
DISCUSSION
To our knowledge, this is the first report describing complete
sequence analysis of the coding regions and the exon-intron
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838boundaries of COL4A1 and COL4A2 in families with KTCN.
Previous studies have revealed a correlation between KTCN
development and histopathological alterations in the structure
of the corneal stroma and basement membrane, including a
loss  of  collagen  concentration  [42]  and  rearrangement  of
collagen fibers [26]. Moreover, several types of collagen,
including collagen type IV have been identified in the cornea
[24], and COL4A1 and COL4A2 expression has been detected
in the human cornea [29]. Finally, we had mapped a locus for
KTCN to 13q32, in close proximity of which COL4A1 and
COL4A2  are  localized  [21].  Given  that  information,  we
hypothesized  that  COL4A1  and  COL4A2  genes  are  good
candidates for causing KTCN in families with linkage to that
locus.
Different studies have revealed several loci and a few
candidate genes for familial KTCN. The first gene proposed
as playing a significant role in KTCN pathogenesis was the
VSX1 (visual system homeobox 1, OMIM 605020) gene. It
was  suggested  that  a  few  disease-causing  mutations  were
present  in  this  gene  [43,44],  but  recent  studies  have  not
confirmed  these  findings  [21,45-47].  Next,  heterozygous
genomic  7-bp  deletion  in  intron  2  of  SOD1  (superoxide
dismutase 1; OMIM 147450) was identified in two families
with KTCN [48,49]. In contrast, other studies have shown that
mutations  in  this  gene  are  not  associated  with  KTCN
pathogenesis  [21,47].  Genetic  analyses  of
COL4A3,COL4A4,COL8A1,  and  COL8A2  genes  have
revealed no pathogenic mutations in patients with KTCN,
indicating  that  other  genetic  factors  cause  the  disease
[50-52].
We identified several single base pair substitutions in the
coding regions of COL4A1 and COL4A2, including one novel
heterozygous change, c.3693G>A in exon 42 of COL4A1.
None  of  the  detected  alterations  segregated  fully
with the affected phenotype in the analyzed members of the
Ecuadorian KTCN families. Among the identified missense
substitutions  in  COL4A1,  one  change,  c.4002A>C  (p.
Gln1334His),  was  observed  more  frequently  in  KTCN
patients than in healthy individuals in family KTCN-014.
However, no significant statistical association of this change
with  familial  disease  could  be  proven  (p=0.056),  and  no
difference in the c.4002A>C allele distribution between the
analyzed  affected  individuals  from  the  remaining  KTCN
families and the Ecuadorian control subjects was discovered
(p=0.17). To predict the impact of the substitutions on the
structure and function of the protein, we used different tools.
All  identified  missense  substitutions  in  COL4A1  and
COL4A2 were predicted by the SIFT, PMUT, PANTHER, and
SNAP  tools  to  have  no  effect,  but  PolyPhen  defined  the
Gln1334His  change  in  COL4A1  as  possibly  damaging.
Glutamine at this position is highly conserved in different
species. Moreover, this change is present in the collagenous
domain of the α1(IV) chain with Gly-X-Y repeats, which
plays a role in the assembly into a triple-helical structure of
the protein [22]. Replacement of the neutral residue (Gln) with
the polar amino acid (His) at the Y position is likely to affect
the protein structure. Nevertheless, further studies should be
performed to determine the functional significance of this
substitution.
To the best of our knowledge, no mutations in COL4A1
were  associated  with  corneal  disease.  The  spectrum  of
COL4A1-related  disorders  included  porencephaly  (OMIM
175780) [53-55], Hereditary Angiopathy with Nephropathy,
Aneurysm and Muscle Cramps (HANAC; OMIM 611773)
[56], and brain small vessel disease with hemorrhage (OMIM
607595) [57]. Recent studies have also revealed an association
between mutations in exon 29 of COL4A1 and Axenfeld-
Rieger anomaly with leukoencephalopathy and stroke [58]. In
our study, none of the previously reported COL4A1 mutations
were identified. The absence of these changes in patients with
KTCN suggests that they are specific to the above-mentioned
disorders only, and are not associated with KTCN in the tested
families.  To  date,  no  mutations  responsible  for  COL4A2-
related human diseases have been reported.
Besides  changes  identified  in  the  coding  regions  of
COL4A1  and  COL4A2,  our  study  revealed  numerous
alterations in introns and UTRs of both genes, including single
base pair substitutions, deletions, and insertions. Fourteen of
these were novel and their clinical significance is not known.
Each of the changes was observed in affected and healthy
individuals  in  the  tested  families.  Because  important
functional  elements  are  located  in  non-coding  regions  of
genes [59] and intronic alterations can result in a deleterious
effect  on  pre-mRNA  splicing  [60],  identification  of  these
sequence variants could be non-accidental. Further research
is needed to delineate the role of these sequence variants.
Recent studies have shown that a mouse with a mutation
in a splice acceptor site of Col4a1 has ocular dysgenesis. The
Figure 1. Multiple sequence alignment of the amino acid sequences of COL4A1 orthologs in different species. Conservation of glutamine (Q)
at the 1334 position is shown in gray.
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839mutation results in a lack of exon 40 from mice’s transcripts
and leads to the accumulation of mis-folded protein in the lens
epithelial cells. Col4a1∆ex40 mice show optic nerve hypoplasia
and anterior segment dysgenesis (ASD) including pigment
Figure 2. Pedigree of the family KTCN-014. Black-filled symbols: individuals with KTCN; open symbols: individuals without KTCN; gray-
filled symbols: individuals with unknown KTCN status. Below each symbol the haplotypes are shown for the coding sequence in genes
COL4A1, COL4A2 and UTRs between them. In COL4A1, the coding regions are surrounded by the markers rs13260 and col4a2_snp, and by
rs35466678 and rs422733 in COL4A2, which were marked by a black frame. Haplotype regions in different colors indicate patterns of
inheritance in the two branches in the pedigree.
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840dispersion, cataracts, and corneal opacifications [61]. Splice
acceptor sites are highly conserved regions in different species
[56]. We detected no alterations in the splice acceptor site in
intron 39 of human COL4A1.
Extended  genetic  studies  executed  in  families  with
KTCN  have  shown  a  high  level  of  genetic  heterogeneity
[62].  The  presence  of  many  putative  loci  supports  the
hypothesis that KTCN is an oligogeneic disease in which
accumulation of sequence variants at several loci cause a
specific KTCN haplotype and may trigger the phenotypic
effect. The absence of mutations in COL4A1 and COL4A2
genes  indicates  that  other  genes  are  involved  in  KTCN
pathogenesis in Ecuadorian families.
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